{"DataElement":{"publicId":"13362262","version":"1","preferredName":"Study Protocol Treatment Course Type","preferredDefinition":"The type of protocol treatment course administered during which relevant observations were recorded. This variable is used across domains to frame the timing of these longitudinal observations.","longName":"13178233v1.00:13138530v1.00","context":"Pediatric Cancer","contextVersion":"1","DataElementConcept":{"publicId":"13178233","version":"1","preferredName":"Study Protocol Treatment Course","preferredDefinition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.:The type of protocol treatment course administered.","longName":"2753771v1.00:13178232v1.00","context":"Pediatric Cancer","contextVersion":"1","ObjectClass":{"publicId":"2753771","version":"1","preferredName":"Study Protocol","preferredDefinition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.","longName":"C70817","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Study Protocol","conceptCode":"C70817","definition":"The formal plan of an experiment or research activity, including the objective, rationale, design, materials and methods for the conduct of the study; intervention description, and method of data analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4E633830-33FD-330A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-29","endDate":null,"createdBy":"UMLLOADER_CANANOLAB","dateCreated":"2008-05-29","modifiedBy":"ONEDATA","dateModified":"2008-05-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"13178232","version":"1","preferredName":"Protocol Treatment Course","preferredDefinition":"The type of protocol treatment course administered.","longName":"C168807","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protocol Treatment Course","conceptCode":"C168807","definition":"The type of protocol treatment course administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6DEBAE0-180C-06F8-E053-731AD00A4E84","latestVersionIndicator":"Yes","beginDate":"2023-03-14","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-03-14","modifiedBy":"JKNABLE","dateModified":"2023-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F6DEBAE0-180D-06F8-E053-731AD00A4E84","latestVersionIndicator":"Yes","beginDate":"2023-03-14","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-03-14","modifiedBy":"JKNABLE","dateModified":"2023-03-14","changeDescription":null,"administrativeNotes":"3/14/23 created for PCDC \"COURSE\" variable. jk","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"13138530","version":"1","preferredName":"Protocol Treatment Course Type","preferredDefinition":"The type of protocol treatment course administered._Something distinguishable as an identifiable class based on common qualities.","longName":"13138530v1.00","context":"Pediatric Cancer","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Adjuvant","valueDescription":null,"ValueMeaning":{"publicId":"2566422","version":"1","preferredName":"ADJUVANT CHEMOTHERAPY","longName":"2566422v1.00","preferredDefinition":"Chemotherapy that is administered subsequent to the main treatment plan to minimize or prevent disease recurrence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adjuvant Chemotherapy","conceptCode":"C15360","definition":"Chemotherapy that is administered subsequent to the main treatment plan to minimize or prevent disease recurrence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D083-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-08","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-08","modifiedBy":"SOKKERL","dateModified":"2023-03-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6C7CCEE-14C1-1D54-E053-731AD00AF82E","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","deletedIndicator":"No"},{"value":"Bridge/Preconsolidation","valueDescription":null,"ValueMeaning":{"publicId":"13168476","version":"1","preferredName":"Bridge Therapy","longName":"13168476v1.00","preferredDefinition":"Therapy intended to transition a patient from one therapy or medication to another or maintain their health or status until they are a candidate for a therapy or have decided on a therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bridge Therapy","conceptCode":"C174554","definition":"Therapy intended to transition a patient from one therapy or medication to another or maintain their health or status until they are a candidate for a therapy or have decided on a therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6C7CCEE-14BD-1D54-E053-731AD00AF82E","latestVersionIndicator":"Yes","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6C7CCEE-14C2-1D54-E053-731AD00AF82E","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","deletedIndicator":"No"},{"value":"Consolidation","valueDescription":null,"ValueMeaning":{"publicId":"3828965","version":"1","preferredName":"Consolidation Therapy","longName":"3828965","preferredDefinition":"Treatment that is given after initial therapy to kill any remaining cancer cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Consolidation Therapy","conceptCode":"C15679","definition":"Treatment that is given after initial therapy to kill any remaining cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2A8BB67-2C14-B6D0-E040-BB89AD43093C","latestVersionIndicator":"Yes","beginDate":"2013-07-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"GDEEN","dateModified":"2023-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6C7CCEE-14C3-1D54-E053-731AD00AF82E","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","deletedIndicator":"No"},{"value":"Continuation","valueDescription":null,"ValueMeaning":{"publicId":"6353418","version":"1","preferredName":"Continuation Therapy Epoch","longName":"6353418","preferredDefinition":"A period in a clinical study during which subjects receive continuation therapy. This therapy is usually different from the therapy given during the induction phase and administered over a longer period of time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Continuation Therapy Epoch","conceptCode":"C123452","definition":"A period in a clinical study during which subjects receive continuation therapy. This therapy is usually different from the therapy given during the induction phase and administered over a longer period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70D0906E-FE14-71BD-E053-F662850A4101","latestVersionIndicator":"Yes","beginDate":"2018-07-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-07-12","modifiedBy":"ONEDATA","dateModified":"2018-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6C7CCEE-14C4-1D54-E053-731AD00AF82E","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","deletedIndicator":"No"},{"value":"Delayed Intensification","valueDescription":null,"ValueMeaning":{"publicId":"12377235","version":"1","preferredName":"Delayed Intensification Therapy","longName":"12377235v1.00","preferredDefinition":"A repeat of the first two months of induction and consolidation chemotherapy in high-risk and very-high-risk ALL protocols with the goal of eliminating residual drug-resistant cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Delayed Intensification Therapy","conceptCode":"C178270","definition":"A repeat of the first two months of induction and consolidation chemotherapy in high-risk and very-high-risk ALL protocols with the goal of eliminating residual drug-resistant cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F27A7354-8F8F-0CEF-E053-731AD00A961E","latestVersionIndicator":"Yes","beginDate":"2023-01-17","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2023-01-17","modifiedBy":"KUMMEROA","dateModified":"2023-01-18","changeDescription":null,"administrativeNotes":"2023.1.18 Alt VM Name added per ticket request CADSR0001913. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6C7CCEE-14C5-1D54-E053-731AD00AF82E","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","deletedIndicator":"No"},{"value":"Intensification","valueDescription":null,"ValueMeaning":{"publicId":"13168477","version":"1","preferredName":"Intensification Therapy","longName":"13168477v1.00","preferredDefinition":"A second round of intense chemotherapy that is higher than the first.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intensification Therapy","conceptCode":"C173105","definition":"A second round of intense chemotherapy that is higher than the first.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6C7CCEE-14BE-1D54-E053-731AD00AF82E","latestVersionIndicator":"Yes","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6C7CCEE-14C6-1D54-E053-731AD00AF82E","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","deletedIndicator":"No"},{"value":"Interim Maintenance","valueDescription":null,"ValueMeaning":{"publicId":"13168478","version":"1","preferredName":"Interim Maintenance Therapy","longName":"13168478v1.00","preferredDefinition":"A less intense phase of chemotherapy in between each course of delayed intensification.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Interim Maintenance Therapy","conceptCode":"C178069","definition":"A less intense phase of chemotherapy in between each course of delayed intensification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6C7CCEE-14BF-1D54-E053-731AD00AF82E","latestVersionIndicator":"Yes","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6C7CCEE-14C7-1D54-E053-731AD00AF82E","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","deletedIndicator":"No"},{"value":"Prephase","valueDescription":null,"ValueMeaning":{"publicId":"13168479","version":"1","preferredName":"Prephase Chemotherapy Treatment","longName":"13168479v1.00","preferredDefinition":"A chemotherapy treatment administered prior to the definitive chemotherapy treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prephase Chemotherapy Treatment","conceptCode":"C168826","definition":"A chemotherapy treatment administered prior to the definitive chemotherapy treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6C7CCEE-14C0-1D54-E053-731AD00AF82E","latestVersionIndicator":"Yes","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6C7CCEE-14C8-1D54-E053-731AD00AF82E","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","deletedIndicator":"No"},{"value":"Unknown","valueDescription":null,"ValueMeaning":{"publicId":"4266671","version":"1","preferredName":"Unknown","longName":"4266671","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6C00C1A-0A55-5623-E040-BB89AD4375BC","latestVersionIndicator":"Yes","beginDate":"2014-04-11","endDate":null,"createdBy":"DWARZEL","dateCreated":"2014-04-11","modifiedBy":"COLBERTM","dateModified":"2023-09-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6C7CCEE-14C9-1D54-E053-731AD00AF82E","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6C7CCEE-14CA-1D54-E053-731AD00AF82E","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","deletedIndicator":"No"},{"value":"Other","valueDescription":null,"ValueMeaning":{"publicId":"6431768","version":"1","preferredName":"Other","longName":"6431768v1.00","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"762A692A-EEF7-29A1-E053-F662850A9EA9","latestVersionIndicator":"Yes","beginDate":"2018-09-18","endDate":null,"createdBy":"WINCHC","dateCreated":"2018-09-18","modifiedBy":"GDEEN","dateModified":"2024-01-22","changeDescription":null,"administrativeNotes":"2023.2.1 Alt VM added per ticket request CADSR0001995. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6C7CCEE-14CB-1D54-E053-731AD00AF82E","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","deletedIndicator":"No"},{"value":"Induction","valueDescription":null,"ValueMeaning":{"publicId":"6859325","version":"1","preferredName":"Induction Therapy","longName":"6859325","preferredDefinition":"The first choice of treatment for a particular type of cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Induction Therapy","conceptCode":"C158876","definition":"The first choice of treatment for a particular type of cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90A8573C-3838-34AF-E053-F662850A7E27","latestVersionIndicator":"Yes","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"GDEEN","dateModified":"2023-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6C7CCEE-14CC-1D54-E053-731AD00AF82E","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","deletedIndicator":"No"},{"value":"Neoadjuvant Therapy","valueDescription":null,"ValueMeaning":{"publicId":"3828966","version":"1","preferredName":"Neoadjuvant Therapy","longName":"3828966","preferredDefinition":"Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy include chemotherapy, radiation therapy, and hormone therapy. It is a type of induction therapy. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2A8BB67-2C37-B6D0-E040-BB89AD43093C","latestVersionIndicator":"Yes","beginDate":"2013-07-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F6C7DEC6-354E-1FD3-E053-731AD00A0EA1","beginDate":"2023-03-13","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-03-13","modifiedBy":"SOKKERL","dateModified":"2023-03-13","deletedIndicator":"No"},{"value":"Maintenance","valueDescription":null,"ValueMeaning":{"publicId":"3828964","version":"1","preferredName":"Maintenance Therapy","longName":"3828964","preferredDefinition":"Continuation of treatment for an extended period of time to prevent relapse.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Maintenance Therapy","conceptCode":"C15688","definition":"Continuation of treatment for an extended period of time to prevent relapse.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E2A8BB67-2BF1-B6D0-E040-BB89AD43093C","latestVersionIndicator":"Yes","beginDate":"2013-07-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-07-29","modifiedBy":"GDEEN","dateModified":"2023-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F901ADDD-9B63-7E78-E053-731AD00AD16A","beginDate":"2023-04-10","endDate":null,"createdBy":"SOKKERL","dateCreated":"2023-04-10","modifiedBy":"SOKKERL","dateModified":"2023-04-10","deletedIndicator":"No"},{"value":"Post-Consolidation","valueDescription":null,"ValueMeaning":{"publicId":"3626580","version":"1","preferredName":"Post Consolidation Therapy","longName":"3626580","preferredDefinition":"Happening at a time subsequent to a reference time; later in time or order.: Chemotherapy treatments given after induction chemotherapy to further reduce the number of cancer cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Consolidation Therapy","conceptCode":"C15679","definition":"Treatment that is given after initial therapy to kill any remaining cancer cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CE8E1484-1109-296D-E040-BB89AD432BEA","latestVersionIndicator":"Yes","beginDate":"2012-11-15","endDate":null,"createdBy":"WONGW","dateCreated":"2012-11-15","modifiedBy":"MMADDINENI","dateModified":"2024-02-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FD7989D2-80AE-0DE3-E053-731AD00ABD24","beginDate":"2023-06-06","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-06-06","modifiedBy":"COLBERTM","dateModified":"2023-06-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"13138529","version":"1","preferredName":"Protocol Treatment Course Type","preferredDefinition":"The type of protocol treatment course administered._Something distinguishable as an identifiable class based on common qualities.","longName":"13138529v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protocol Treatment Course","conceptCode":"C168807","definition":"The type of protocol treatment course administered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67DA29E-4885-53AE-E053-731AD00AEEF6","latestVersionIndicator":"Yes","beginDate":"2023-03-09","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-09","modifiedBy":"COLBERTM","dateModified":"2023-03-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F67DA29E-4886-53AE-E053-731AD00AEEF6","latestVersionIndicator":"Yes","beginDate":"2023-03-09","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-09","modifiedBy":"COLBERTM","dateModified":"2023-06-06","changeDescription":null,"administrativeNotes":"3/9/23 Created per PCDC metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"12173174","version":"1","longName":"PCDC Aggregated Dictionary","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"12173175","version":"1","longName":"Protocol","context":"Pediatric Cancer"},{"publicId":"12173184","version":"1","longName":"Course Timing","context":"Pediatric Cancer"}]},{"publicId":"13954630","version":"1","longName":"All Pediatric Core CDEs","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"14599256","version":"1","longName":"Clinical Observation","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"COURSE","type":"PCDC Alt Name","context":"Pediatric Cancer"},{"name":"Course","type":"Ped Cancer Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Course","url":null,"context":"Pediatric Cancer"},{"name":"Ped Cancer Instruction","type":"Instructions","description":"The protocol treatment \"course\" during which relevant observations were recorded. This variable is used across domains to frame the timing of these longitudinal observations and reduce the number of redundant variables needed to report similar concepts.","url":null,"context":"Pediatric Cancer"}],"origin":"PCDC:Pediatric Cancer Data Commons","workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"F951CF31-84F4-29B1-E053-731AD00A9E2D","latestVersionIndicator":"Yes","beginDate":"2023-04-14","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-14","modifiedBy":"JKNABLE","dateModified":"2024-02-22","changeDescription":null,"administrativeNotes":"2/22/24 Added Ped Core Alts, CSI per PCDC/MW recommendations. jk; 4/14/23 Curated for PCDC. BF","unresolvedIssues":null,"deletedIndicator":"No"}}